(Q38106681)

29 August 2017

title

Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience (English)

1 reference

29 August 2017

0 references

1 reference

3

Jes Olesen

0 references

Jakob Møller Hansen

object named as

Jakob Møller Hansen

series ordinal

2

0 references

Məsud Aşina

series ordinal

1

object named as

Messoud Ashina

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

33

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

540-553

1 reference

Nitroglycerin headache and nitroglycerin-induced primary headaches from 1846 and onwards: a historical overview and an update

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The International Classification of Headache Disorders: 2nd edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Brainstem activation specific to migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Brain stem activation in spontaneous human migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

A positron emission tomographic study in spontaneous migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Glyceryl trinitrate triggers premonitory symptoms in migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Premonitory symptoms in migraine: an electronic diary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Focal headache during balloon inflation in the internal carotid and middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Arterial Supersensitivity to Nitric Oxide (Nitroglycerin) in Migraine Sufferers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Middle cerebral artery velocity correlates with nitroglycerin-induced headache onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Lack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Magnetic resonance angiography shows dilatation of the middle cerebral artery after infusion of glyceryl trinitrate in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Nitric oxide synthase inhibition in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The prophylactic effect of valproate on glyceryltrinitrate induced migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Migraine and the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Trigger factors in migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Cerebral Blood Flow Velocities are Reduced During Attacks of Unilateral Migraine Without Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Evidence for a vascular factor in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Does the unfavorable pharmacokinetic and pharmacodynamic profile of the iNOS inhibitor GW273629 lead to inefficacy in acute migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The pharmacodynamics of sumatriptan in nitroglycerin-induced headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Nitroglycerin provocation in normal subjects is not a useful human migraine model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The effect of propranolol on glyceryltrinitrate-induced headache and arterial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The Nitric Oxide Hypothesis of Migraine and Other Vascular Headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Mast cell degranulation activates a pain pathway underlying migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

No increase of calcitonin gene-related peptide in jugular blood during migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

CGRP may play a causative role in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Nitroglycerin-Induced Headache is Not Dependent on Histamine Release: Support For a Direct Nociceptive Action of Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Migraine can be induced by sildenafil without changes in middle cerebral artery diameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Cerebral haemodynamic response or excitability is not affected by sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Dipyridamole May Induce Migraine in Patients With Migraine Without Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The headache-inducing effect of cilostazol in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Origin of PACAP-immunoreactive nerve fibers innervating the subarachnoidal blood vessels of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Neuronal messengers in the human cerebral circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

PACAP38 induces migraine-like attacks in patients with migraine without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The PACAP receptor: a novel target for migraine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Prostaglandin E2(PGE2) induces headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2 (PGD2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Prostacyclin (epoprostenol) induces headache in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Activation of central trigeminovascular neurons by cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Occipital activation in glyceryl trinitrate induced migraine with visual aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Functional MRI-BOLD of visually triggered headache in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Microemboli may link spreading depression, migraine aura, and patent foramen ovale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Genetic models of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Calcitonin Gene-Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Coexisting typical migraine in familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Pain characteristics of the acute migraine attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

New appendix criteria open for a broader concept of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Familial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Familial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Histamine Inhalation is a Specific but Insensitive Laboratory Test for Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Dipyridamole Dilates Large Cerebral Arteries Concomitant to Headache Induction in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

Finding new drug targets for the treatment of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102412475234

21 January 2018

Identifiers

DOI

10.1177/0333102412475234

1 reference

29 August 2017

1 reference